Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
11/07/2016 | 22h23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
11/07/2016 | 18h10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
05/07/2016 | 23h02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 21h37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 21h05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 21h00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20h34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h25 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 15h23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |